相关实验视频

Updated: Sep 9, 2025

Testing the In Vitro and In Vivo Efficiency of mRNA-Lipid Nanoparticles Formulated by Microfluidic Mixing
08:55

Testing the In Vitro and In Vivo Efficiency of mRNA-Lipid Nanoparticles Formulated by Microfluidic Mixing

Published on: January 20, 2023

12.0K

基于RNA的脂质纳米粒子癌症疫苗的定向交付和增强稳定性的人工智能驱动策略

Ripesh Bhujel1, Viktoria Enkmann2, Hannes Burgstaller2

  • 1Dhulikhel Hospital, Dhulikhel 45210, Nepal.

Pharmaceutics
|August 28, 2025
PubMed
概括

人工智能 (AI) 通过优化脂质纳米颗粒 (LNP) 以稳定和瘤向来加速癌症疫苗的开发. 人工智能整合提高效率,降低成本,为负担得起的个性化癌症免疫疗法铺平道路.

关键词:
人工智能 (AI)高通量选免疫疗法脂质纳米颗粒 (LNP)机器学习优化情况个性化RNA-LNP癌症疫苗稳定性有针对性的交付

更多相关视频

Using Lipid Nanoparticles for the Delivery of Chemically Modified mRNA into Mammalian Cells10:02

Using Lipid Nanoparticles for the Delivery of Chemically Modified mRNA into Mammalian Cells

Published on: June 10, 2022

2.3K
Generation of Cationic Nanoliposomes for the Efficient Delivery of In Vitro Transcribed Messenger RNA08:29

Generation of Cationic Nanoliposomes for the Efficient Delivery of In Vitro Transcribed Messenger RNA

Published on: February 1, 2019

10.2K

相关概念视频

Experimental RNAi02:15

Experimental RNAi

RNA interference (RNAi) is a cellular mechanism that inhibits gene expression by suppressing its transcription or activating the RNA degradation process. The mechanism was discovered by Andrew Fire and Craig Mello in 1998 in plants. Today, it is observed in almost all eukaryotes, including protozoa, flies, nematodes, insects, parasites, and mammals. This precise cellular mechanism of gene silencing has been developed into a technique that provides an efficient way to identify and determine the...
6.2K